• Something wrong with this record ?

rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

H. Wang, R. Medina, J. Ye, Y. Zhang, S. Chakraborty, A. Valenzuela, O. Uher, K. Hadrava Vanova, M. Sun, X. Sang, DM. Park, J. Zenka, MR. Gilbert, K. Pacak, Z. Zhuang

. 2024 ; 11 (14) : e2308280. [pub] 20240131

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24014483

Grant support
Intramural Research Programs of the National Institutes of Health (NIH), including the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Despite strides in immunotherapy, glioblastoma multiforme (GBM) remains challenging due to low inherent immunogenicity and suppressive tumor microenvironment. Converting "cold" GBMs to "hot" is crucial for immune activation and improved outcomes. This study comprehensively characterized a therapeutic vaccination strategy for preclinical GBM models. The vaccine consists of Mannan-BAM-anchored irradiated whole tumor cells, Toll-like receptor ligands [lipoteichoic acid (LTA), polyinosinic-polycytidylic acid (Poly (I:C)), and resiquimod (R-848)], and anti-CD40 agonistic antibody (rWTC-MBTA). Intracranial GBM models (GL261, SB28 cells) are used to evaluate the vaccine efficacy. A substantial number of vaccinated mice exhibited complete regression of GBM tumors in a T-cell-dependent manner, with no significant toxicity. Long-term tumor-specific immune memory is confirmed upon tumor rechallenge. In the vaccine-draining lymph nodes of the SB28 model, rWTC-MBTA vaccination triggered a major rise in conventional dendritic cell type 1 (cDC1) 12 h post-treatment, followed by an increase in conventional dendritic cell type 2 (cDC2), monocyte-derived dendritic cell (moDC), and plasmacytoid dendritic cell (pDC) on Day 5 and Day 13. Enhanced cytotoxicity of CD4+ and CD8+ T cells in vaccinated mice is verified in co-culture with tumor cells. Analyses of immunosuppressive signals (T-cell exhaustion, myeloid-derived suppressor cells (MDSC), M2 macrophages) in the GBM microenvironment suggest potential combinations with other immunotherapies for enhanced efficacy. In conclusion, the authors findings demonstrate that rWTC-MBTA induces potent and long-term adaptive immune responses against GBM.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014483
003      
CZ-PrNML
005      
20240905134406.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/advs.202308280 $2 doi
035    __
$a (PubMed)38298111
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Wang, Herui $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA $1 https://orcid.org/0000000322934819
245    10
$a rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells / $c H. Wang, R. Medina, J. Ye, Y. Zhang, S. Chakraborty, A. Valenzuela, O. Uher, K. Hadrava Vanova, M. Sun, X. Sang, DM. Park, J. Zenka, MR. Gilbert, K. Pacak, Z. Zhuang
520    9_
$a Despite strides in immunotherapy, glioblastoma multiforme (GBM) remains challenging due to low inherent immunogenicity and suppressive tumor microenvironment. Converting "cold" GBMs to "hot" is crucial for immune activation and improved outcomes. This study comprehensively characterized a therapeutic vaccination strategy for preclinical GBM models. The vaccine consists of Mannan-BAM-anchored irradiated whole tumor cells, Toll-like receptor ligands [lipoteichoic acid (LTA), polyinosinic-polycytidylic acid (Poly (I:C)), and resiquimod (R-848)], and anti-CD40 agonistic antibody (rWTC-MBTA). Intracranial GBM models (GL261, SB28 cells) are used to evaluate the vaccine efficacy. A substantial number of vaccinated mice exhibited complete regression of GBM tumors in a T-cell-dependent manner, with no significant toxicity. Long-term tumor-specific immune memory is confirmed upon tumor rechallenge. In the vaccine-draining lymph nodes of the SB28 model, rWTC-MBTA vaccination triggered a major rise in conventional dendritic cell type 1 (cDC1) 12 h post-treatment, followed by an increase in conventional dendritic cell type 2 (cDC2), monocyte-derived dendritic cell (moDC), and plasmacytoid dendritic cell (pDC) on Day 5 and Day 13. Enhanced cytotoxicity of CD4+ and CD8+ T cells in vaccinated mice is verified in co-culture with tumor cells. Analyses of immunosuppressive signals (T-cell exhaustion, myeloid-derived suppressor cells (MDSC), M2 macrophages) in the GBM microenvironment suggest potential combinations with other immunotherapies for enhanced efficacy. In conclusion, the authors findings demonstrate that rWTC-MBTA induces potent and long-term adaptive immune responses against GBM.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a glioblastom $x metabolismus $7 D005909
650    _2
$a CD8-pozitivní T-lymfocyty $7 D018414
650    12
$a vakcíny $x metabolismus $7 D014612
650    _2
$a dendritické buňky $7 D003713
650    _2
$a imunita $7 D007109
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
700    1_
$a Medina, Rogelio $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Ye, Juan $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Zhang, Yaping $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Chakraborty, Samik $u NE1 Inc., New York, NY, 10022, USA
700    1_
$a Valenzuela, Alex $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Uher, Ondrej $u Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA
700    1_
$a Hadrava Vanova, Katerina $u Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA
700    1_
$a Sun, Mitchell $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Sang, Xueyu $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Park, Deric M $u John Theurer Cancer Center, HUMC, Hackensack Meridian School of Medicine, 92 2nd St, Hackensack, NJ, 07601, USA
700    1_
$a Zenka, Jan $u Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, 37005, Czech Republic
700    1_
$a Gilbert, Mark R $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA
700    1_
$a Pacak, Karel $u Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA
700    1_
$a Zhuang, Zhengping $u Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 10022, USA $1 https://orcid.org/0000000200097370
773    0_
$w MED00208721 $t Advanced science $x 2198-3844 $g Roč. 11, č. 14 (2024), s. e2308280
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38298111 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134400 $b ABA008
999    __
$a ok $b bmc $g 2143937 $s 1226349
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 11 $c 14 $d e2308280 $e 20240131 $i 2198-3844 $m Advanced science $n Adv Sci (Weinh) $x MED00208721
GRA    __
$p Intramural Research Programs of the National Institutes of Health (NIH), including the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Archiving options